Normaten

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Normaten

This section establishes the definitive identity and unique characteristics of the medicine Normaten, presented for patient clarity.

Property Description
Active ingredient Atenolol
Form Tablet (Oral)
Pharmacological class beta-Adrenergic Receptor Antagonist (Beta Blocker)
Common use To manage heart rate and blood pressure
Origin Synthetic

Identity, Classification, and Composition

Normaten is a prescription medication defined by its active pharmaceutical ingredient, Atenolol. This substance is a product of chemical synthesis, classifying the drug as a single-ingredient, synthetic compound. The medicine is primarily supplied for oral administration as a solid tablet. As a beta blocker, Normaten belongs to the foundational pharmacological group known as beta-Adrenergic Receptor Antagonists.

Differentiation and Foundational Benefit

A crucial distinguishing feature of Atenolol is its classification as a cardioselective beta1-adrenergic receptor antagonist. This specific selectivity means its action is preferentially focused on the heart's beta-1 receptors, distinguishing it from non-selective beta blockers that affect broader systems. This targeted nature characterizes its role in stabilizing heart function and reducing cardiac workload. Consequently, the general therapeutic purpose of Normaten is derived from this selective action: it helps to manage the heart’s demand for oxygen and reduce the physical force exerted on arterial walls. This core benefit is typically utilized to support overall cardiovascular function and maintain healthy blood pressure levels.

Regulatory References

  1. WHO Model List of Essential Medicines

What side effects are possible with Normaten?

Possible Side Effects and Safety Information

The safety profile of Normaten (atenolol) is established by regulatory documents and classifies potential adverse reactions based on their statistical frequency and physiological impact. The effects are categorized by the System-Organ Class (SOC) and by the likelihood of occurrence, strictly adhering to standards set by government health authorities like the FDA and EMA.


Frequency-Classified Undesirable Effects

The most common reported adverse reactions, affecting 1 to 10 users in 100, include bradycardia (slow heart rate), general fatigue, and cold extremities. Gastrointestinal disturbances, such as nausea or diarrhea, are also classified as common. Effects listed as rare (affecting 1 to 10 users in 10,000) include mood alterations, paresthesia, visual disturbances, and alopecia.


Serious Adverse Reactions and Safety Constraints

Official labeling documents significant safety concerns, including the potential for deterioration of existing heart failure and the risk of bronchospasm, particularly in susceptible individuals. The drug is contraindicated in situations such as severe bradycardia, uncontrolled heart failure, cardiogenic shock, and second- or third-degree heart block. This defines the high-level safety restrictions for its use.


Contextual and Population Safety Notes

The regulatory profile specifies safety notes for certain patient groups. Individuals with renal impairment require specific consideration and potential dosage adjustment due to the drug's primary route of excretion. The label also notes that abrupt discontinuation of treatment, especially in patients with ischemic heart disease, can be associated with severe angina exacerbation or potential myocardial infarction.

Overdose and Emergency Response

Any suspected overdose with Normaten (Atenolol) is considered a medical emergency due to its potential for life-threatening cardiotoxicity. Seek immediate medical attention and contact emergency services for any known or suspected overdose event.

Documented Overdose Manifestations

Official regulatory documents define overdose presentation primarily through signs of profound beta-blockade, which necessitate urgent intervention:

  • Profound Bradycardia: An excessively slow heart rate.
  • Severe Hypotension: Dangerously low blood pressure.
  • Acute Heart Failure: Rapid deterioration of heart function.
  • Systemic Effects: Documented signs include lethargy, drowsiness, bronchospasm, and hypoglycemia (low blood sugar), which requires monitoring.

Severe or life-threatening outcomes, such as Cardiogenic Shock, Cardiac Arrest, and Coma, are documented as potential consequences that mandate hospitalization and continuous monitoring.

Required Emergency Actions

The official labeling notes that no specific antidote is known for Atenolol overdose; therefore, management is symptomatic and supportive. Procedures to limit drug absorption, such as Activated Charcoal or Gastric Lavage, are described for recent ingestion. Interventions explicitly documented to counteract severe cardiac effects include administration of Glucagon for profound myocardial depression and Atropine for severe bradycardia. Due to the drug's elimination route, patients with Renal Impairment require special consideration and management.

Therapeutic Uses of Normaten

Quick Facts

  • Support for elevated blood pressure: May be considered to assist in managing high blood pressure (hypertension).
  • Aid in chest discomfort: Used in the long-term management of chronic, stable chest pain associated with coronary artery conditions (angina pectoris).
  • Post-cardiac event support: May be used to assist in the care of patients following a heart attack (acute myocardial infarction) who are hemodynamically stable.

What Normaten Treats: Main Uses and Benefits

Normaten (atenolol) is a prescription medication utilized in a medical management plan. The therapeutic domains of this agent primarily involve addressing heart and circulatory conditions.

Key areas of use include:

  1. Management of High Blood Pressure (Hypertension): The medication is indicated to assist in lowering elevated blood pressure levels. This therapeutic action is intended to contribute to comprehensive cardiovascular risk management.
  2. Long-term Angina Pectoris Management: It is used as a component of the long-term plan for individuals experiencing chest discomfort (angina pectoris) linked to coronary artery disease.
  3. Post-Myocardial Infarction Support: Normaten is employed to provide care for patients after they have experienced a heart attack, specifically in individuals considered hemodynamically stable, as part of reducing cardiovascular mortality.

This agent is frequently used alongside other therapeutic strategies, such as lifestyle changes, to achieve treatment goals.

Eligibility and Restrictions for Use

The eligibility for using Normaten (atenolol) is strictly defined by official regulatory documentation and is based primarily on pre-existing cardiovascular status and organ function. Only adults are generally approved for use.

Populations Who Must Not Use Normaten (Contraindications)

Use is contraindicated (must not be used) if a patient has any of the following conditions, as stated in the label:

  • Known hypersensitivity to atenolol or its components.
  • Second- or third-degree atrioventricular (AV) heart block.
  • Severe bradycardia (very slow heart rate).
  • Cardiogenic shock or overt cardiac failure (decompensated heart failure).
  • Severe bronchial asthma or severe bronchial hyperresponsiveness.
  • Untreated pheochromocytoma or metabolic acidosis.

Eligibility Restrictions and Special Populations

Population Regulatory Status
Pediatric (Under 18) Use not established; generally not recommended.
Older Adults Requires cautious dose selection, often starting lower, due to decreased renal function.
Renal Impairment Requires mandatory dose adjustment based on creatinine clearance.
Pregnancy/Lactation Restricted/Caution; associated with fetal growth restriction and risk of infant bradycardia.
Diabetes Mellitus Requires caution, as the drug may mask signs of acute hypoglycemia.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction scope

Category Details
Medicinal product categories Calcium Channel Blockers (non-dihydropyridine), Antiarrhythmic Agents, Catecholamine-Depleting Drugs, NSAIDs, and Antacids.
Specific interacting medicines Verapamil, Diltiazem, Clonidine, Reserpine, Digitalis Glycosides, and Indomethacin.
Mechanistic basis (documented) Additive effects on cardiac function (negative chronotropy/inotropy), pharmacodynamic antagonism, and altered gastrointestinal absorption.
Timing-based interaction rules Normaten must be discontinued several days prior to the gradual cessation of Clonidine to prevent rebound hypertension. Administration with antacids should be separated by at least two hours to maintain optimal absorption.
Population-specific notes Elimination is primarily renal; cumulative effects and increased exposure may occur in patients with impaired renal function, which can increase interaction severity.
Interaction-related restrictions Co-administration with Verapamil and Diltiazem is formally classified as a contraindicated combination.

Interaction classifications (high-level)

Classification Details
Interaction severity Contraindicated Combinations, Clinically Significant Interactions (requiring procedural management).
Regulatory basis Based on government-approved labeling sources, including the FDA and national health authorities.
Interaction-context constraints Includes the procedural constraint for the ordered withdrawal of Clonidine and the physiological constraint requiring renal function monitoring.

Resulting interaction structure

Official interaction statements:

  • Co-administration with non-dihydropyridine calcium channel blockers is contraindicated due to the risk of combined cardiac depression.
  • The blood pressure-lowering effect may be reduced by co-administered Nonsteroidal Anti-inflammatory Drugs (NSAIDs), such as Indomethacin, a documented pharmacodynamic interaction.
  • Interaction with other agents that slow heart rate, including Digitalis Glycosides or Amiodarone, can result in additive effects on cardiac function.

Connection to the overall interaction profile (2–4 sentences):

Regulatory documentation defines Normaten’s interaction structure primarily through its pharmacodynamic risks, necessitating formal restrictions for combined use with agents that further depress heart function. The profile also highlights timing-based constraints for co-administered products that affect its gastrointestinal absorption or its specific renal clearance pathway. This ensures official guidelines address risks related to both combined physiological effects and altered exposure.

Mechanism of Action

Normaten, containing atenolol, functions as a beta1-selective adrenergic receptor antagonist (beta-blocker). The drug selectively targets and binds to beta-1 adrenergic receptors primarily located in cardiac tissue (myocardium and sinoatrial/atrioventricular nodes) and, to a lesser extent, in the juxtaglomerular apparatus of the kidney.

By competitive antagonism, atenolol prevents the binding and action of endogenous catecholamines (e.g., norepinephrine, epinephrine) at these beta1 sites. This interaction inhibits the Gs-protein coupling, leading to a reduction in the intracellular concentration of cyclic adenosine monophosphate (cAMP) and subsequently, diminished activation of Protein Kinase A (PKA).

The downstream cascade in cardiomyocytes involves reduced phosphorylation of L-type calcium channels and phospholamban. This decreases the influx of calcium and its subsequent release from the sarcoplasmic reticulum. The system-level physiological consequence is a decrease in both chronotropy (heart rate) and inotropy (contractile force) due to sympathetic tone modulation. Furthermore, inhibition of beta1 receptors in the kidney suppresses the release of renin, modulating the renin-angiotensin-aldosterone system (RAAS) and contributing to reduced systemic vascular resistance.

Dosage and Administration Information

How to Use Normaten

Normaten (atenolol) is administered either as an oral tablet for long-term therapy or as an intravenous injection for initial acute care, such as after a heart attack. The tablets are typically available in strengths of 25 mg, 50 mg, and 100 mg.

Standard Dosing and Frequency

For chronic conditions like high blood pressure, the treatment is generally initiated with a dose of 25 mg or 50 mg taken once daily. The dose may be increased, if necessary, after one or two weeks up to a usual maximum of 100 mg daily for hypertension. For chronic stable chest discomfort, the maintenance dose is typically 100 mg daily, which may be given as a single dose or divided into two doses.

Indication Initial Dose (Oral) Maximum Daily Dose (Oral)
Hypertension 25 mg to 50 mg once daily 100 mg
Angina Pectoris 50 mg once daily 200 mg

Administration Conditions and Adjustments

Tablets should be swallowed whole with water and may be taken with or without food. The dosing protocol requires adjustments for specific populations and circumstances.

  • Renal Impairment: Because the medicine is cleared by the kidneys, the dosage must be reduced when kidney function is severely impaired (Creatinine Clearance <35 mL/ min), with maximum doses lowered to prevent accumulation.
  • Older Adults: A lower starting dose, such as 25 mg daily, may be appropriate for older patients.
  • Discontinuation: Treatment must not be stopped abruptly. The dose must be reduced gradually, typically over a period of one to two weeks.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Normaten

Evidence Supporting Use in High Blood Pressure Management

Research exploring the use of Normaten for high blood pressure includes Randomized Controlled Trials and subsequent Meta-analyses which combine results from many separate studies. These research scenarios primarily examined changes in systolic and diastolic blood pressure (BP) readings. Beyond the numbers, studies also monitored long-term outcomes related to cardiovascular events, specifically tracking the occurrence of stroke, heart attack, and mortality. Studies described measurements of changes in blood pressure levels across various adult groups. However, when trials examined major outcomes, reports indicated that the data show patterns related to variability in findings when compared to alternative treatments.

Evidence Supporting Use in Angina Pectoris Management

Studies have explored the use of Normaten in conditions involving periods of heightened symptoms, specifically in adults experiencing chronic, stable chest discomfort (angina pectoris). Researchers measured changes in the frequency of anginal episodes, the need for symptom-reducing medication, and the patient's ability to exercise before discomfort began. Studies reported how symptoms evolved in the observed populations, with trials describing patterns related to changes in the frequency of chest discomfort and changes in certain functional measures during exercise testing. The research structure offers limited information specifically dedicated to tracking long-term major cardiovascular events for patients treated solely for chronic stable angina.

Evidence Supporting Use Following a Heart Attack

The evidence for this use involves a set of Clinical Trials and Systematic Reviews that focused on adults who survived a heart attack. The research examined outcomes related to survival and recurrence. Studies monitored rates of all-cause mortality, cardiovascular mortality, and the risk of experiencing a recurrent heart attack. A foundational set of trials reported measurements where patterns related to cardiovascular mortality were observed in patients who received this treatment following a heart attack. Analysis of subgroups suggests that outcome findings may be mixed, especially for patients with preserved cardiac function following an uncomplicated event.

Gaps and Areas of Scientific Uncertainty

One key research limitation is that many foundational clinical studies used to approve this medicine were conducted decades ago, meaning they may not fully reflect outcomes when compared against current standard therapies. For high blood pressure, the evidence indicates that comparative evidence is limited regarding alternative drug classes. Furthermore, for some conditions, research has primarily examined short-term symptom changes, leading to limited information for long-term outcomes.

Frequently Asked Questions (FAQ)

Common questions about Normaten (FAQ)


Q: How quickly should I expect Normaten to start working?

According to official product information, while some initial effects may be observed sooner, the full effect for managing blood pressure is typically observed within a period of one to two weeks of initiating consistent treatment. Consistent daily dosing helps the medicine reach steady-state levels in the body over approximately five to seven days.


Q: Can Normaten cause weight gain?

Weight gain is not explicitly listed as one of the common (1 to 10%) or frequent adverse reactions in core regulatory documents for this drug. However, official safety notes for the broader class of medicine indicate that unexplained weight gain, especially alongside swelling, can be a sign of the worsening of a pre-existing condition, such as heart failure, which is a change that warrants seeking medical guidance.


Q: Does Normaten make you feel tired or dizzy?

Regulatory documents classify fatigue (a feeling of tiredness) as a common side effect of Normaten. Dizziness is also a reported undesirable effect, which is typically associated with the medicine's action of lowering blood pressure. Regulatory warnings indicate that patients may need to exercise caution when starting treatment, as the potential for these effects exists.


Q: Are there any common foods or drinks I should avoid while using Normaten?

Official administration instructions state that Normaten tablets may be taken either with or without food. Official documents do not specify any common foods that must be restricted, though some authoritative sources advise separating the medicine's administration from certain high-mineral drinks or supplements by at least two hours to maintain proper absorption in the digestive system.


Q: Does Normaten interact with common pain relievers like ibuprofen?

Yes, official regulatory documents warn about a potential interaction between this medicine and a class of pain relievers called Nonsteroidal Anti-inflammatory Drugs (NSAIDs), which includes ibuprofen. The official statement indicates that co-administration of an NSAID may reduce the blood pressure-lowering effect of Normaten.


Q: Is it safe to use Normaten with anxiety medicines?

The official interaction profile does not list every anxiety medicine individually but includes warnings about combining Normaten with agents that have an additive effect on cardiac function or blood pressure. Since many medications can affect these systems, official information advises reviewing all current medicines and supplements with a healthcare provider to understand potential additive effects.


Q: Can men use Normaten without worrying about certain side effects?

When reviewing the safety profile, some regulatory documents mention that sexual dysfunction or erectile dysfunction has been reported as a side effect associated with this class of beta-blocker medicine. Individuals who notice such changes may wish to discuss the concern with their healthcare provider.


Q: Can Normaten be crushed or split in half?

The administration instructions do not authorize crushing or splitting the tablets. Official guidelines state that Normaten tablets should be swallowed whole with water to ensure the medicine is properly absorbed.


Q: Does Normaten affect kidney function?

The medicine is primarily cleared from the body by the kidneys. For this reason, official prescribing guidelines require a mandatory dosage adjustment for patients who already have severe renal impairment (poor kidney function) to prevent the drug from accumulating. Official warnings and information focus on the need for dosage adjustment when kidney function is already severely impaired.


Q: Does Normaten affect the consumption of alcohol in moderation?

Regulatory documents do not contain an absolute restriction on alcohol use. However, official information generally advises caution, as alcohol can potentially increase the risk of side effects like dizziness or lightheadedness due to combined effects on blood pressure.


Q: Do I need to get blood tests regularly while taking Normaten?

The need for blood tests depends on individual patient circumstances. Official prescribing information strictly requires monitoring of kidney function (creatinine clearance) to help guide dosage in patients who have pre-existing renal impairment. This monitoring helps ensure the medicine is cleared from the body correctly.


Q: Does Normaten interact with herbal remedies like St. John's Wort?

Official drug interaction documents typically focus on other prescription and over-the-counter medicines. However, the regulatory guidance for all patients is to always inform their healthcare provider about all vitamins, supplements, and herbal remedies being used, as potential effects on the medicine’s action cannot be ruled out.


Q: Can Normaten cause swelling in the ankles or feet?

Swelling in the ankles or feet (edema) is not listed as a common side effect of Normaten. However, regulatory warnings list this type of swelling as a reported sign of worsening heart failure or fluid retention, which is a change that warrants prompt medical assessment.


Q: Does Normaten affect the ability to drive or operate machinery?

Regulatory patient warnings recommend caution when engaging in activities such as driving or operating machinery until the individual is aware of how the medicine affects them. This is due to the potential for side effects, such as dizziness or fatigue, which may impair physical abilities.


Q: Is Normaten used for anything besides high blood pressure?

Yes, regulatory documents approve Normaten for several uses. In addition to high blood pressure (hypertension), it is also indicated to manage chronic, stable chest discomfort (angina pectoris) and to reduce the risk of certain adverse events following a heart attack (myocardial infarction).


Q: Is Normaten the same kind of medicine as a 'water pill'?

No, Normaten is not the same as a 'water pill' (diuretic). Normaten is officially classified as a beta-adrenergic receptor antagonist, commonly known as a beta-blocker. Beta-blockers work by affecting heart function, while diuretics work by helping the kidneys remove excess fluid. The two classes are often used together in treatment.


Q: How does Normaten compare to other common high blood pressure medicines?

Regulatory documents indicate that clinical evidence and research findings for Normaten may show variability when compared to certain other classes of high blood pressure treatments. A patient's overall health profile helps inform a healthcare provider on the appropriate use of Normaten relative to other available treatments.


Q: Is it normal to feel a change in my heart rate after starting Normaten?

A change in heart rate is consistent with the drug's intended action. The medicine is designed to reduce the heart's activity, and regulatory documents list bradycardia (a slow heart rate) as a common side effect.


Q: Can Normaten affect sleep?

Yes, official safety information indicates that Normaten can potentially affect sleep. The documented adverse reactions include reports of the patient experiencing vivid dreams or nightmares.


Q: Can Normaten cause a cough?

Cough is not typically listed as a common or frequent side effect of Normaten in core regulatory data. However, for susceptible individuals, the drug class is associated with a risk of bronchospasm (tightening of the airways), which can cause difficulty breathing and coughing.


Q: Is there a generic version of Normaten available?

Yes, the active ingredient in Normaten, which is atenolol, is widely available and typically offered as a lower-cost generic medication.


Q: What special considerations apply to people with diabetes using Normaten?

Use requires caution for people with diabetes. Regulatory warnings state that Normaten may mask certain signs of acute hypoglycemia (very low blood sugar), specifically by reducing the rapid heart rate usually associated with this event. Official guidance emphasizes the importance of blood sugar monitoring for individuals with diabetes who are using this medicine.


Q: What is the official guidance for using Normaten while planning pregnancy?

The drug's use is officially classified with Restricted/Caution regarding pregnancy and lactation due to potential risks, including fetal growth restriction. Official guidance indicates that patients who are planning or trying to conceive should always discuss this medication with their healthcare provider.


Q: Does Normaten affect athletic performance?

Regulatory and pharmacological information notes that Normaten reduces the heart rate and the force of the heart's contraction. This intended effect may impact a person’s ability to reach maximum heart rate and may affect endurance or stamina during strenuous athletic activity.


Q: Are there different brand names for the same active ingredient as Normaten?

Yes, the active ingredient in Normaten is atenolol. This ingredient has been marketed and sold under various other brand names, including the well-known brand name Tenormin.


Q: What is the highest dosage of Normaten that has been studied?

The highest dose approved for treatment in official prescribing information is 200 mg daily, which is authorized for patients with angina pectoris. For context, some early clinical trials investigating the drug’s potential used doses as high as 900 mg daily, though this is not a standard therapeutic dose.

How should Normaten be stored and disposed of?

How to Store and Dispose of Normaten (Atenolol)

Normaten tablets must be stored at controlled room temperature, specifically between 20 C to 25 C (68 F to 77 F), with permitted brief excursions up to 30 C. To maintain product stability, the medicine must be protected from moisture, excessive heat, and freezing. The product should be kept in its original container and the container must remain tightly closed.

Storage Requirement Condition
Temperature Controlled room temperature
Protection Protect from moisture and excessive heat
Container Keep in original, tightly closed container

For household safety, Normaten must be kept out of the sight and reach of children at all times. Disposal of any unused or expired tablets must follow local requirements and approved pharmaceutical take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Normaten found in:

A-Z Index: